Baxter International (BAX:NYSE) Annual Reports & Investor Relations Material

Overview

Baxter International Inc., a global healthcare product developer, offers a wide range of medical products and services to patients and healthcare providers across the world. The company specializes in peritoneal and hemodialysis therapies, intravenous therapies, infusion pumps, drug reconstitution devices, and pharmacy compounding services. It also provides oncology drug platforms, anesthesia and critical care products, and parenteral nutrition therapies to patients in various medical institutions including nursing homes, rehab centers, and hospitals. Baxter International also offers connected care solutions such as devices, software, communications, and integration technologies to diagnose, treat, and manage a wide range of illnesses and diseases. The company distributes its products through independent distributors, drug wholesalers, and specialty pharmacies in over 100 countries around the world. Besides, it has collaborations with Celerity Pharmaceutical, LLC, and Miromatrix Medical Inc. to develop acute care generic injectable premix and oncolytic molecules and treatments for patients with acute liver failure, respectively. Founded in 1931, Baxter International Inc. is based in Deerfield, Illinois.

Frequently Asked Questions

What is Baxter International's ticker?

Baxter International's ticker is BAX

What exchange is Baxter International traded on?

The company's shares trade on the NYSE stock exchange

Where are Baxter International's headquarters?

They are based in Deerfield, Illinois

How many employees does Baxter International have?

There are 10,000+ employees working at Baxter International

What is Baxter International's website?

It is baxter.com

What type of sector is Baxter International?

Baxter International is in the Healthcare sector

What type of industry is Baxter International?

Baxter International is in the Medical Instruments & Supplies industry

Who are Baxter International's peers and competitors?

The following five companies are Baxter International's industry peers:

- West Pharmaceutical Services

- AngioDynamics

- LeMaitre Vascular

- Mesa Laboratories Inc.

- Envista